SCHEMBL26845914

SCHEMBL26845914

Cc1ccc2c(c1)CN(C(=O)CS(=O)(=O)c1ccccn1)C2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 3/20 0.43
▸ DPP8 Q6V1X1 2/20 0.40
▸ DPP9 Q86TI2 2/20 0.40
▸ DPP7 Q9UHL4 1/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ ADRB2 P07550 1/20 0.39
▸ RAB9A P51151 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24815671 0.88 ALDH1A1 (0.44) NAMPTHSD17B10ALDH1A1KDM4ERAB9A
SCHEMBL29986504 0.88 ALDH1A1 (0.44) NAMPTHSD17B10ALDH1A1KDM4ERAB9A
SCHEMBL29986903 0.87 ESR1 (0.40) NAMPTALDH1A1RAB9ASMN1; SMN2POLB
SCHEMBL24815700 0.87 ESR1 (0.40) NAMPTALDH1A1RAB9ASMN1; SMN2POLB
SCHEMBL29987244 0.86 NAMPT (0.46) NAMPTMEN1KMT2AHSD17B10ALDH1A1
SCHEMBL24815715 0.86 NAMPT (0.46) NAMPTMEN1KMT2AHSD17B10ALDH1A1
SCHEMBL24814393 0.86 NAMPT (0.46) NAMPTDPP8DPP9DPP7
SCHEMBL29987274 0.86 NAMPT (0.46) NAMPTDPP8DPP9DPP7
SCHEMBL24814718 0.80 AOC3 (0.49) NAMPTALDH1A1MAPT
SCHEMBL29986210 0.80 AOC3 (0.49) NAMPTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH NAMPT 2850/4885DPP8 4457/4885DPP9 4490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback